Literature DB >> 30115567

RNA Polymerase III as a Gatekeeper to Prevent Severe VZV Infections.

Madalina E Carter-Timofte1, Søren R Paludan2, Trine H Mogensen3.   

Abstract

In most individuals, varicella zoster virus (VZV) causes varicella upon primary infection and zoster during reactivation. However, in a subset of individuals, VZV may cause severe disease, including encephalitis. Host genetics is believed to be the main determinant of exacerbated disease manifestations. Recent studies have demonstrated that defects in the DNA sensor RNA polymerase III (POL III) confer selective increased susceptibility to VZV infection, thus providing fundamental new insight into VZV immunity. Here we describe the roles of POL III in housekeeping and immune surveillance during VZV infection. We present the latest knowledge on the role of POL III in VZV infection and discuss outstanding questions related to the role of POL III in VZV immunity, and how this insight can be translated into clinical medicine.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA sensing; RNA polymerase III; interferon; varicella zoster virus

Mesh:

Substances:

Year:  2018        PMID: 30115567     DOI: 10.1016/j.molmed.2018.07.009

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  14 in total

Review 1.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

2.  The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.

Authors:  Alan C Kessler; Richard J Maraia
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

Review 3.  RNA polymerase III and antiviral innate immune response.

Authors:  Nayef Jarrous; Alexander Rouvinski
Journal:  Transcription       Date:  2021-02-24

4.  The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.

Authors:  Manutea C Serrero; Virginie Girault; Sebastian Weigang; Todd M Greco; Ana Ramos-Nascimento; Fenja Anderson; Antonio Piras; Ana Hickford Martinez; Jonny Hertzog; Anne Binz; Anja Pohlmann; Ute Prank; Jan Rehwinkel; Rudolf Bauerfeind; Ileana M Cristea; Andreas Pichlmair; Georg Kochs; Beate Sodeik
Journal:  Elife       Date:  2022-04-27       Impact factor: 8.713

5.  BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle.

Authors:  Xubing Long; Jing Yang; Xiaolin Zhang; Ziwei Yang; Yang Li; Fan Wang; Xiaojuan Li; Ersheng Kuang
Journal:  EMBO Rep       Date:  2020-11-23       Impact factor: 9.071

Review 6.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

Review 7.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

Review 8.  Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination.

Authors:  Nathan B Price; Charles Grose
Journal:  Vaccines (Basel)       Date:  2021-01-06

Review 9.  An overview of viral infections of the nervous system in the immunosuppressed.

Authors:  Peter G E Kennedy
Journal:  J Neurol       Date:  2020-10-13       Impact factor: 4.849

Review 10.  Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.

Authors:  Ethan H Heusel; Charles Grose
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.